Correlation Between Reviva Pharmaceuticals and Alnylam Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Alnylam Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Alnylam Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Alnylam Pharmaceuticals, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Alnylam Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Alnylam Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Alnylam Pharmaceuticals.
Diversification Opportunities for Reviva Pharmaceuticals and Alnylam Pharmaceuticals
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Reviva and Alnylam is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Alnylam Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alnylam Pharmaceuticals and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Alnylam Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alnylam Pharmaceuticals has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Alnylam Pharmaceuticals go up and down completely randomly.
Pair Corralation between Reviva Pharmaceuticals and Alnylam Pharmaceuticals
Given the investment horizon of 90 days Reviva Pharmaceuticals Holdings is expected to generate 4.24 times more return on investment than Alnylam Pharmaceuticals. However, Reviva Pharmaceuticals is 4.24 times more volatile than Alnylam Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Alnylam Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest 114.00 in Reviva Pharmaceuticals Holdings on November 27, 2024 and sell it today you would earn a total of 32.00 from holding Reviva Pharmaceuticals Holdings or generate 28.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Reviva Pharmaceuticals Holding vs. Alnylam Pharmaceuticals
Performance |
| Timeline |
| Reviva Pharmaceuticals |
| Alnylam Pharmaceuticals |
Reviva Pharmaceuticals and Alnylam Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Reviva Pharmaceuticals and Alnylam Pharmaceuticals
The main advantage of trading using opposite Reviva Pharmaceuticals and Alnylam Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Alnylam Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will offset losses from the drop in Alnylam Pharmaceuticals' long position.| Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |